Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on Jul 24, 2024 1:43pm
64 Views
Post# 36146495

RE:FDA approval

RE:FDA approval
Solid1 wrote: Everything stands or falls with FDA approval - that's the only thing that counts. But you don't even know the pharmaceutical partner or the exact status. The notification may come at any time or it may never come 


Don't agree.  Even without Epidiolex, there is enough business in Germany, Brazil and Australia to drive the SP to multiples from here.

Pharma is the unicorn moonshot but I agree that we shouldn't but any value to it yet but I disagree that we don't know about it.  We know it's Epidiolex, we know the partner is one of the patent litigants and one of the ones that hasn't settled yet.  But at what point, if ever, the partner settles and what that means to the partner and by extension LABS is anyones guess.  Any of the trial stuff is literally years away.  Epidiolex may not be, but given the court action, who knows when and if that gets taken care of.  As CADInvestor says, we're owed some detail on that.
<< Previous
Bullboard Posts
Next >>